GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 4DMedical Ltd (ASX:4DX) » Definitions » Asset Impairment Charge

4DMedical (ASX:4DX) Asset Impairment Charge : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is 4DMedical Asset Impairment Charge?

4DMedical's Asset Impairment Charge for the six months ended in Dec. 2023 was A$0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.


4DMedical Asset Impairment Charge Historical Data

The historical data trend for 4DMedical's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4DMedical Asset Impairment Charge Chart

4DMedical Annual Data
Trend Jun21 Jun22 Jun23
Asset Impairment Charge
- - -

4DMedical Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Asset Impairment Charge Get a 7-Day Free Trial - - - - -

4DMedical Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.


4DMedical Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of 4DMedical's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


4DMedical (ASX:4DX) Business Description

Traded in Other Exchanges
Address
700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053
4DMedical Ltd is a company whose principal activities is medical research technology and the development of a non?invasive respiratory imaging solution using four?dimensional imaging. The four-dimensional lung imaging technology utilises mathematics models and algorithms to convert X-ray scans into quantitative data which helps the physicians to manage patients with respiratory diseases and diseases of the lung.

4DMedical (ASX:4DX) Headlines

No Headlines